Validation of the Indonesian version of the non-motor symptoms scale for Parkinson’s disease

Stella Natadidjaja; Sekplin Sekeon; Rizal Tumewah

doi:10.18203/2320-6012.ijrms20230692

Authors

Stella Natadidjaja Department of Neurology, Faculty of Medicine, Sam Ratulangi University/R.D. Kandou Hospital Manado, Indonesia
Sekplin A. S. Sekeon Department of Neurology, Faculty of Medicine, Sam Ratulangi University/R.D. Kandou Hospital Manado, Indonesia
Rizal Tumewah Department of Neurology, Faculty of Medicine, Sam Ratulangi University/R.D. Kandou Hospital Manado, Indonesia

DOI:

https://doi.org/10.18203/2320-6012.ijrms20230692

Keywords:

PD, Non-motor symptoms scale, Validation, Reliability, Non-motor symptoms

Abstract

Background: Non-motor symptoms are common, have a wide range of symptoms, and have emerged as a key determinant of poor quality of life (QoL) in Parkinson’s disease (PD) patients, contributing to severe disability, and shortened life expectancy. However, although common, the non-motor symptoms of PD are often not well recognized and under-reported in clinical practice. This study aimed to translate the origin non-motor symptoms scale for PD (NMSS), which was written in English, into an Indonesian version and to evaluate its reliability and validity.

Methods: Linguistic validation and psychometric analysis of the Indonesian version of NMSS were conducted in 70 patients with PD using a cross-sectional study. The acceptability, reliability, and construct validity of NMSS were analyzed. Test-retest reliability was assessed over a time interval of 14 days in all patients.

Results: The 70 patients were assessed (median age 67.5 years; 57.1% males; median duration of illness 48 months; median Hoehn and Yahr stage: 3). Mean NMSS was 51.86 (SD 44.02; median 37). Neither floor nor ceiling effect was observed on the Indonesian version of the NMSS total score. Validity test using Pearson product moment showed all 9 domains Indonesian version of NMSS were valid (r=0.506-0.805, p<0.001). NMSS total score showed satisfactory reliability (Cronbach’s α coefficient on the total score was 0.852, the range for domains: 0.146-0.814).

Conclusions: Indonesian version of NMSS showed good reliability and validity for the assessment of non-motor symptoms in PD patients in Indonesia.

Metrics

Metrics Loading ...

References

Lee HM, Koh SB. Many faces of Parkinson’s disease: non-motor symptoms of Parkinson’s disease. JMD. 2015;8(2):92-7.

Valkovic P, Harsany J, Hanakova M, Martinkova J, Benetin J. Nonmotor Symptoms in early- and advanced-stage Parkinson’s disease patients on dopaminergic therapy: how do they correlate with quality of life? Neurology. 2014;2014:1-4.

Syamsudin T, Akbar M. Buku panduan tatalaksana penyakit Parkinson dan gangguan gerak lainnya. PERDOSSI. 2015.

Ragab OA, Elheneedy YA, Bahnasy WS. Non-motor symptoms in newly diagnosed Parkinson’s disease patients. Egypt J Neurol Psychiatry Neurosurg. 2019;55(1):24.

Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. The Lancet Neurol. 2009;8(5):464-74.

Chaudhuri KR, Healy DG, Schapira AHV. Non-motor symptoms of Parkinson’s disease: diagnosis and management. The Lancet Neurol. 2006;5:235-45.

Sauerbier A, Jitkritsadakul O, Titova N, Klingelhoefer L, Tsuboi Y, Carr H et al. Non-motor symptoms assessed by non-motor symptoms questionnaire and non-motor symptoms scale in Parkinson’s disease in selected asian populations. Neuroepidemiology. 2017;49(1-2):1-17.

Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P et al. The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an international pilot study. Mov Disord. 2007;22(13):1901-11.

Van Wamelen DJ, Martinez‐Martin P, Weintraub D, Schrag A, Antonini A, Falup‐Pecurariu C et al. The non‐motor symptoms scale in Parkinson’s disease: validation and use. Acta Neurol Scand. 2021;143(1):3-12.

Aninditha T, Wiratman W, editors. Buku Ajar Neurologi. Vol. Buku 1. Tangerang: Penerbit Kedokteran Indonesia. 2017;342.

Leman MA. Cara praktis melakukan uji validitas alat ukur penelitian. Yogyakarta: Gosyen Publishing. 2018;133.

Hastono SP. Modul analisis data. Jakarta: Fakultas Kesehatan Masyarakat UI. 2006;219.

Heale R, Twycross A. Validity and reliability in quantitative studies. Evid Based Nurs. 2015;18(3):66-7.

Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropractic Med. 2016;15(2):155-63.

Cova I, Di Battista ME, Vanacore N, Papi CP, Alampi G, Rubino A et al. Validation of the Italian version of the non-motor symptoms scale for Parkinson’s disease. Parkinsonism Rel Disorders. 2017;34:38-42.

Carod-Artal FJ, Martinez-Martin P. Independent validation of the non motor Symptoms Scale for Parkinson’s disease in Brazilian patients. Parkinsonism Rel Disord. 2013;19(1):115-9.

Wang G, Hong Z, Cheng Q, Xiao Q, Wang Y, Zhang J et al. Validation of the Chinese non-motor symptoms scale for Parkinson’s disease: results from a Chinese pilot study. Clin Neurol Neurosurg. 2009;111(6):523-6.

Koh SB, Kim JW, Ma HI, Ahn TB, Cho JW, Lee PH et al. Validation of the Korean-Version of the nonmotor symptoms scale for Parkinson’s disease. J Clin Neurol. 2012;8(4):276.